{
  "service": "Tech Flow",
  "publisher": "Svět Androida",
  "view": "item",
  "ranking": "chronological, by the time the link was added",
  "notice": "Links are curated by the newsroom. Content belongs to the original sources — cite source_url.",
  "count": 1,
  "items": [
    {
      "id": 34,
      "title": "Longevity Firms Push Montana to Become Hub for Biohacking, Experimental Treatments",
      "source_url": "https://www.technologyreview.com/2026/07/30/1140942/montana-experimental-medical-hub-pushed-forward-right-to-try",
      "source_domain": "technologyreview.com",
      "permalink": "https://techflow.svetandroida.cz/en/tip/longevity-firms-push-montana-to-become-hub-for-biohacking-experimental",
      "status": "published",
      "image": "https://wp.technologyreview.com/wp-content/uploads/2026/07/montana-treatments2.jpg?resize=1200,600",
      "summary": "Montana is implementing expanded right-to-try legislation that allows experimental drug sales without FDA approval. Biotech companies can sell unproven treatments to anyone who consents and pays after passing review by an independent board and paying a $12,500 application fee. Longevity advocates helped drive the legislation, though initial interest comes mainly from oncology and neurodegenerative disease patients.",
      "summary_generated_by": "ai",
      "submitted_by": "Petr Mišák",
      "submitted_kind": "editor",
      "published_at": "2026-08-05T10:43:42Z",
      "age_hours": 1448,
      "votes": 0,
      "source_opens": 2,
      "source_language": "en",
      "our_article": null,
      "enrichment": {
        "text": true,
        "summary": true,
        "entities": true,
        "vector": true,
        "title_source": "dodany"
      },
      "zpracovani": [
        {
          "co": "titulek",
          "stav": "zobrazeno",
          "duvod": "TitulekOdesilatele",
          "zprava": "Titulek zadal odesílatel tipu."
        },
        {
          "co": "obrazek",
          "stav": "zobrazeno",
          "duvod": "NahledDostupny",
          "zprava": "Náhledový obrázek je k dispozici."
        },
        {
          "co": "shrnuti",
          "stav": "zobrazeno",
          "duvod": "RozborUspesny",
          "zprava": "Shrnutí vzniklo z rozboru zdroje."
        },
        {
          "co": "qa",
          "stav": "zobrazeno",
          "duvod": "QaVygenerovano",
          "zprava": "Otázky a odpovědi k tématu vznikly z rozboru."
        },
        {
          "co": "poznamka",
          "stav": "prazdne-po-pravu",
          "duvod": "AutorBezPoznamky",
          "zprava": "Autor tipu poznámku nenapsal."
        },
        {
          "co": "entity",
          "stav": "zobrazeno",
          "duvod": "EntityRozpoznany",
          "zprava": "Rozbor rozpoznal jisté entity k tématu."
        },
        {
          "co": "souvisi",
          "stav": "zobrazeno",
          "duvod": "PodobnaPolozkaNalezena",
          "zprava": "V proudu se našly podobné položky."
        },
        {
          "co": "indexace",
          "stav": "zobrazeno",
          "duvod": "ObsahExistuje",
          "zprava": "Stránka smí do indexu vyhledávačů — obsah vznikl."
        },
        {
          "co": "publikace",
          "stav": "zobrazeno",
          "duvod": "Internal",
          "zprava": "The newsroom has the details."
        }
      ]
    }
  ]
}